SK134291A3 - The intrauterine contraceptive device with incidental elimination of menstrual pain - Google Patents

Abstract

The intrauterine contraceptive device is created based on the dilatation blockade (1) made of the swelling hydrophilic gel being equipped with a fixing enlargement (2) on one end with the conic extension (3) on the other end. The dilatation blockade (1) is equipped with a manipulation facility (4), a fixation of which is assured with the use of the naps (5).

Description

Technical field

The invention relates to an intrauterine contraceptive body with the optional elimination of menstrual pains intended to prevent pregnancy in the period between two subsequent periods.

The state of the art

The technique used to carry out contraception or sterility for contraception so far has many disadvantages. Sterility by ligature or interruption of the fallopian tubes is a difficult and costly procedure to be performed under anesthesia. The major disadvantage of these procedures is the impermeability of the fallopian tubes, which means a permanent impossibility to conceive. A woman who opts for such sterility is virtually excluded from having her own child. This, in turn, leads to mental and physical complications and often causes problems in partner relationships.

Contraceptive drug methods, using hormonal preparations, do not guarantee the absence and pathological consequences resulting from their use. Mechanical Methods of Preventing Pregnancy Using Condoms and Different Types of ICO1P; pessaries bring considerable practice in practice. The diaphragm should be inserted before intercourse in the case of long-term diaphragm placement, the vaginal wall, inflammation and pressure sores are often irritated. These disadvantages are exacerbated by expansion pessaries, which, by virtue of their widespread post-introduction, provide a complete prevention of pregnancy, but cause much more to the inconvenience. The method of contraception using an intrauterine body, inserted professionally into the uterine cavity, then does not guarantee complete reliability and efficacy and may cause undesirable side effects such as inflammation and bleeding. Thus, no methods or contraceptive methods are known which have no adverse side effects, even pathological, including, for example, a worsening of chronic cervical inflammation, or which guarantee complete reliability of preventing pregnancy.

SUMMARY OF THE INVENTION

These disadvantages are virtually completely eliminated by the intrauterine contraceptive body, with the possible elimination of menstrual pain according to the invention, which is based on a dilatation block made of a swelling hydrophilic gel.

The intrauterine contraceptive body according to the invention not only provides the possibility of performing a reliable, rapid and inexpensive procedure to prevent pregnancy, but also enables a slight or dilatation of the uterine throat to reduce or even eliminate menstrual pain, particularly in young women. It is perfectly fixed in the uterine throat where it is inserted, while reliably preventing pregnancy and, in addition, due to its own physiological dilatation according to the shape of the uterine throat, it does not cause unwanted side effects.

BRIEF DESCRIPTION OF THE DRAWINGS

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 illustrates an expansion blockade prior to insertion in a non-dilatated state; and FIG. 2 shows an established dilatation block and a swollen state upon sealing and some expansion of the cervix.

DETAILED DESCRIPTION OF THE INVENTION

According to FIG. 1, the dilatation block 1 is formed in the form of a longitudinal body, e.g. sticks. At one end, the expansion blockade 1 is preferably provided with a cross-sectional fixation 2, for example of a round shape. At the other end, the dilatation blockade 1 is preferably provided with a conical extension 3 to prevent spontaneous movement of the inserted dilatation blockade 1 and finally also to suitably fill the mouth of the uterus 6. The dilatation blockade 1 is formed of a sterile swelling gel which swells in the cervix 6 prevents the penetration of spermatozoids. The dilatation block 1 is preferably provided with a handling means 4, for example a fiber, fixed in the dilatation block 1 and designed to pull the dilatation block 1 out. The handling means 4, for example the fiber, is led out of the expansion block 1. Its fastening is carried out, for example, by knots 5 on the handling means 4, in this case the fiber. The knots 5 are located inside the produced dilatation block 11, instead of the knots 5, for example, cross-sections of the handling means 4 (not shown) can be used. Fastening of the handling means 4 is already achieved during the production of the expansion blockade 1, for example during its casting or molding. However, the attachment of the handling means 4 to or in the dilatation blockade may also be different from that shown or shown. For example, node 5 or extension may be only one.

The dilatation blockade 1 is introduced upon completion of menstruation by a physician. The introduction can be effected, for example, optionally by means of a simple aid in the position of the uterus-anexvex-6a. The dilatation blockade 1 is inserted through the fixation magnification 2 into the vagina 7 and further into the uterine throat 6 until the cone widening 3 is reached. After the dilatation blockade is introduced, the hydrophilic gel is swollen from about 1 day to form the dilatation blockade. i. This reliably and tightly fills the neck of the uterus 6 at its mouth. Expansion block 1 i

4 swells in the shape of the interior of the cervix 6 and expands slightly at this point, thereby achieving a menstrual antalgia, thus eliminating pain. Before the next menstruation the fibers of the dilatation blockade 1 are then removed by means of the handling means 4.

The dilatation block 6 may also be of another shape. It is important that it fills the uterine throat 6 closely. Instead of the stop conical extension 3, another, e.g., funnel-shaped, concave magnification (not shown) may be used.

The dilatation blockade 1 may be provided with one or more pure active substances released upon their placement in the throat of the uterus 6. These may be, for example, substances with a bactericidal action such as sulfonamides or antibiotics, in particular rol itetracycline, especially for cervical action. . Specific anti-AIDS agents, for example azidothymidine (AZT), may also be used. It is also possible to use a corticoid substance, for example hydrocortisone, to alter the nature of the cervical mucus in the case of immunological incompetence of the mucus with sperm. It is also possible to admix spermicides, for example silver.

Industrial usability

The invention can be industrially used, in particular, by producing dilatation blocks in the pharmaceutical or chemical industry.

Claims (1)

Patent claims W Wte- f / PRINT / * / Intrauterine contraceptive body with possible removal of menstrual pain, characterized by? characterized in that it is formed by an expansion block made of a swelling hydrophilic gel. Intrauterine contraceptive characterized in that the dilatation (1) has the shape of a rod. Intrauterine contraceptives characterized in that the dilatation block (1) is provided at one end with a fixative cross-sectional enlargement (2). Intrauterine contraceptive (D body according to point 1, blockade body according to point 1, body according to (2) is. Intrauterine contraceptive device according to claim 3, characterized in that the dilatation block (1) is provided at one end with a conical extension (3). Intrauterine contraceptive body according to claim 1, characterized in that a handling means (4), for example a fiber, is fastened in the dilatation block (1). Intrauterine contraceptive device according to claim 6, characterized in that the handling means (4) is fastened in the dilatation block (1) by one knot (5) formed on the class (4) and placed inside (D. Intrauterine contraceptive body according to claim 6, characterized in that the handling means (4) is fastened in the dilatation block (1) by at least one enlargement of its cross-section. at least a manipulative proslatory blockade Λ / 6. The intrauterine contraceptive body of claim 1, wherein the dilatation block (1) is provided with at least one spermicidal substance, for example silver. Intrauterine contraceptive body according to claim 1, characterized in that the dilatation block (1) is equipped with at least one active bactericidal substance, for example rol itetracycline. 11. Intrauterine device according to claim 1, characterized in that the dilatation block (1) is equipped with a specific anti-AIDS agent, for example azidothymidine. 12. The intrauterine contraceptive body of claim 1, wherein the dilatation block (D is provided with a corticoid substance, e.g. a hydrocortis zone).